Innovent Biologics and Takeda sign global strategic partnership

TransThera publishes clinical results from US-based Phase 2 trial of tinengotinib in CCA

Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase

OncoPrecision's ONC001 data selected for presentation at 67th ASH Annual Meeting and Exposition

Immedica gets UAE approval for Zepzelca maintenance treatment

HEALTH Magazine's Beyond Pink Event Brings Experts and Survivors Together to Spotlight Women's Health in the UAE

Imugene Ltd enters co-development collaboration with JW Therapeutics (Shanghai)

Sichuan Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy clinical study results published in Annals of Oncology

Mendus reports trial follow-up data supporting potential of vididencel in high-risk ovarian cancer

SK Biopharmaceuticals signs licence agreement with Wisconsin Alumni Research Foundation

GE HealthCare receives FDA clearance for AI-powered Pristina Recon DL mammography system

BeOne Medicines' sonrotoclax granted FDA Priority Review for relapsed or refractory mantle cell lymphoma

AstraZeneca wins US approval for Imfinzi as first perioperative immunotherapy in early gastric and GEJ cancer

Curasight begins phase 1 trial of uTREAT in glioblastoma

Prestige Biopharma agrees Tuznue licence and supply deal for Latin America